文献速递糖尿病

一种新的糖尿病分型:从发病机制到治疗迈向精准糖尿病学

A novel diabetes typology: towards precision diabetology from pathogenesis to treatment.
PubMed 文献 · Diabetologia · 2022-01-04

本综述讨论近期研究证据,提出除严重自身免疫性糖尿病外,还可识别出严重胰岛素缺乏型糖尿病、严重胰岛素抵抗型糖尿病、轻度肥胖相关型糖尿病和轻度年龄相关型糖尿病四个亚组。这些亚组在临床特征、疾病进展及并发症发生上呈现不同模式,其中严重胰岛素抵抗型糖尿病的心血管、肾脏和脂肪肝疾病风险最高。虽然有人提出这些亚组患者可能从分层治疗中获益,但需随机对照试验评估任何重新分型的临床效用。

要点

  • 除严重自身免疫性糖尿病外,可识别出四个糖尿病亚组,各亚组临床特征与并发症模式不同。
  • 严重胰岛素抵抗型糖尿病的心血管、肾脏和脂肪肝疾病风险最高。
  • 分层治疗获益的假设需随机对照试验评估,重新分型的临床效用尚待验证。

核心结论

  • 新的糖尿病分型概念已使研究者更深入了解糖尿病的多彩图景,并推动该领域进展,精准糖尿病学未来可能成为现实。

研究设计与样本

  • 本综述讨论近期关于糖尿病复杂性的研究证据,提出新的糖尿病亚组(亚型)。

主要发现

  • 最广泛重复和验证的方法识别出除严重自身免疫性糖尿病外的四个亚组:严重胰岛素缺乏型糖尿病、严重胰岛素抵抗型糖尿病、轻度肥胖相关型糖尿病和轻度年龄相关型糖尿病。
  • 这些亚组呈现不同的临床特征、疾病进展以及合并症和并发症发生模式。
  • 严重胰岛素抵抗型糖尿病显示心血管、肾脏和脂肪肝疾病风险最高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出需随机对照试验评估任何重新分型的临床效用。
  • 原文指出若干方法学和实践问题需进一步研究:定义亚组和推导糖尿病照护建议的统计方法;亚组随时间的稳定性;用于重新分型的最佳数据集(如表型 vs 基因型);研究结果的跨种族普适性;以及在临床常规照护中的适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The current classification of diabetes, based on hyperglycaemia, islet-directed antibodies and some insufficiently defined clinical features, does not reflect differences in aetiological mechanisms and in the clinical course of people with diabetes. This review discusses evidence from recent studies addressing the complexity of diabetes by proposing novel subgroups (subtypes) of diabetes. The most widely replicated and validated approach identified, in addition to severe autoimmune diabetes, four subgroups designated severe insulin-deficient diabetes, severe insulin-resistant diabetes, mild obesity-related diabetes and mild age-related diabetes subgroups. These subgroups display distinct patterns of clinical features, disease progression and onset of comorbidities and complications, with severe insulin-resistant diabetes showing the highest risk for cardiovascular, kidney and fatty liver diseases. While it has been suggested that people in these subgroups would benefit from stratified treatments, RCTs are required to assess the clinical utility of any reclassification effort. Several methodological and practical issues also need further study: the statistical approach used to define subgroups and derive recommendations for diabetes care; the stability of subgroups over time; the optimal dataset (e.g. phenotypic vs genotypic) for reclassification; the transethnic generalisability of findings; and the applicability in clinical routine care. Despite these open questions, the concept of a new classification of diabetes has already allowed researchers to gain more insight into the colourful picture of diabetes and has stimulated progress in this field so that precision diabetology may become reality in the future.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Herder C, Roden M. A novel diabetes typology: towards precision diabetology from pathogenesis to treatment. Diabetologia. 2022. PMID: 34981134. doi:10.1007/s00125-021-05625-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。